← Back to articles

What Is a Convertible Note and Why It Is Not Really Debt

The Naming Confusion: Debt by Name, Equity by Nature

A convertible note is called a "note," implying debt. But it's not debt in the traditional sense. Traditional debt (a loan) requires repayment with interest at a specified maturity date. You borrow $500K at 8% interest, you owe $540K in three years regardless of business outcomes. Convertible notes are different: they're designed to convert into equity (typically in the next funding round) and never be repaid as debt.

The term "note" is historical. Early convertible instruments were debt-like with conversion features. Modern convertible notes (especially Simple Agreements for Future Equity, or SAFEs) are purely equity instruments with some debt characteristics (a small interest rate to compensate investors for the delay in conversion). But functionally, they're equity futures: agreements that say "you're investing now, you'll own equity in the future when we do a proper equity round."

This distinction matters enormously for how you should think about convertible notes. If you think of them as debt that must be repaid, you'll make poor capital allocation decisions. If you understand them as equity that will dilute you in a future round, you'll make better decisions.

The Mechanics of Conversion

When you raise a convertible note, the investor gives you cash today. The note sits on the books as a liability (from an accounting perspective). It specifies: (1) principal amount (the investment), (2) interest rate (usually 2-8% annually, often not paid in cash but added to principal), (3) conversion trigger (what event converts the note to equity), (4) valuation cap (if applicable), (5) discount rate (if applicable).

When the conversion trigger fires (typically a Series A equity funding round), the note automatically converts into equity at a discounted price. Example: you raised a $500K convertible note with a 20% discount and a $5M valuation cap. In your Series A, the lead investor proposes a $6M post-money valuation. Without the discount, you'd issue equity at that $6M valuation. But the note has a 20% discount, so it converts at $4.8M (20% off the $6M valuation). Alternatively, if the Series A valuation is $2M, the note holder uses the valuation cap instead (converts at $5M, the cap, not at the lower post-money). The note holder gets whichever is more favorable.

The result: the note investor owns a certain percentage of equity determined by their principal plus accrued interest, divided by the valuation at which they convert. They never receive a cash payment. They own stock in the company.

Why Convertible Notes Are Not Debt

Traditional debt has a maturity date and must be repaid. Convertible notes have a maturity date, but repayment is not the primary outcome. The primary outcome is conversion into equity. The maturity date is a "long stop" date that forces conversion or negotiation if a funding round hasn't happened by then (typically 2-4 years after investment).

In practice, nearly 100% of convertible notes convert into equity in a future funding round. They rarely mature and require repayment. When maturity approaches without a funding round, the investor and company typically agree to extend the maturity or convert at a negotiated valuation rather than demand repayment (which would destroy the company and net the investor nothing).

From a balance sheet perspective, accountants may show convertible notes as a liability until they convert. But economically, they're equity. The investor has accepted dilution (they own whatever percentage their investment represents post-conversion). They've accepted contingency (if the company fails, they lose the investment; if it succeeds, they own equity). This is equity risk and equity return profile, not debt.

SAFEs vs. Traditional Convertible Notes

Simple Agreements for Future Equity (SAFEs) are a modern, simpler version of convertible notes. SAFEs eliminate some debt characteristics: they don't accrue interest, they don't have a maturity date (technically), and they're explicitly equity instruments. A SAFE says: "You're investing $500K today. When we do an equity round, this investment converts to equity at a discounted price (or valuation cap)."

SAFE is cleaner than a traditional convertible note because it removes the confusion: no interest, no maturity date, purely equity. But the economics are nearly identical. A $500K SAFE with a 20% discount is equivalent to a $500K convertible note with 20% discount and minimal interest.

Choose SAFE over convertible note for simplicity (SAFE is 3 pages, note is 10+ pages). Choose convertible note if you want alignment with sophisticated investors who expect debt-like characteristics (interest accrual, maturity date). Most seed-stage companies should use SAFE.

Valuation Cap vs. Discount: The Two Conversion Mechanisms

Most convertible notes or SAFEs include either a valuation cap or a discount (or both). These determine the price at which the note converts.

Valuation cap: the maximum valuation at which the note converts. If your cap is $5M and your Series A is priced at $8M, the note converts as if your valuation is $5M (favorable to the investor). If your Series A is priced at $3M, the note converts at $3M (not using the cap, just at the actual valuation). The cap protects investors: "We'll invest $500K now. If you're worth $5M or less when you raise Series A, we get the benefit. If you're worth more than $5M, we don't, but we still get an equity stake."

Discount: the note converts at a percentage discount to the Series A price. If your Series A is $6M post-money and the note has a 20% discount, it converts at $4.8M (20% off the $6M). The discount also protects investors: "We'll invest early at a discount to your future price, compensating us for our early risk."

When both are present (cap and discount), the investor gets whichever is more favorable. This can create perverse incentives: if you raise your Series A at a high valuation, the cap might limit the investor to that cap price (they don't get the benefit of the high valuation). This is why founders should negotiate the cap carefully—a cap too low makes your Series A expensive for the note investor and can create tension.

Interest and Accrual

Many convertible notes accrue interest (typically 2-8% annually). This interest is usually not paid in cash. Instead, it's added to the principal amount that converts into equity. A $500K note with 4% interest for 2 years before conversion will convert as if it were a $540,800 investment (the principal plus interest).

Interest serves two purposes: (1) it compensates the investor for the time value of money (they're waiting for a future funding event), (2) it increases the stake they'll own when they convert (higher principal = higher equity percentage). The interest rate is typically tied to market rates for debt or venture debt (~5-8%). It's usually negotiable.

SAFE notes typically don't accrue interest (they have no maturity date, so no time-based interest). Instead, the investor gets compensatory value through the discount or valuation cap.

Dilution and Future Fundraising Implications

This is where understanding convertible notes as equity matters. When you raise a convertible note, you're not taking on debt that doesn't dilute future founders. You're deferring dilution to a future funding round. In your Series A, the note will convert and dilute all existing shareholders (founders and employees with equity).

If you raise $1M in convertible notes pre-seed, and your Series A values the company at $5M post-money with a $2M Series A raise, the note holders will own roughly ($1M principal + interest) / $5M valuation = ~20% of the company. That 20% comes out of the founder dilution pool. If you thought you'd own 80% post-Series A, you'll own ~65% instead (80% × (1 - 0.20)).

This math is often ignored when founders raise seed-stage convertible notes. They think "we're getting capital without dilution" (technically true pre-seed) but forget that dilution will happen in Series A. The effect is cumulative: if you raise $500K pre-seed (converts at 20% equity), then $2M seed at $4M valuation (investor owns 33% post-seed), you've now been diluted by both instruments. When you reach Series A, you'll have multiple cap tables to reconcile and significant dilution.

Comparing Convertible Notes to Equity Investment

Imagine two scenarios:

Scenario A: Raise $500K equity at $2.5M pre-money ($3.5M post-money). Investor owns 14.3% ($500K / $3.5M). You retain 85.7%.

Scenario B: Raise $500K convertible note with 20% discount and $4M cap. In Series A at $6M post-money, the note converts at $4M (cap is more favorable than 20% discount on $6M). Investor owns 12.5% ($500K / $4M). You retain 87.5%.

In this example, the convertible note is slightly more favorable to you (less dilution) because the cap limits the investor's benefit from your higher Series A valuation. But if your Series A is at $3M post-money, the note investor loses (they're diluted by having invested early at a discount to your now-lower valuation).

The point: convertible notes defer valuation determination. If your company is worth more at Series A than you expected, the note is less favorable to you (investor gets a discount on a higher valuation). If you're worth less, it's more favorable to you (investor is stuck with the cap, limiting their upside). Equity today gives you certainty on dilution; convertible notes give you uncertainty but potential optionality.

When Maturity Causes Problems

Most convertible notes mature in 2-4 years. If you haven't raised a Series A by then, the note either: (1) extends maturity, (2) converts at a negotiated valuation, or (3) the investor demands repayment (rare, because a struggling company can't typically repay). Most often, the founder and investor renegotiate.

If you have multiple convertible notes with different maturity dates, this becomes complicated. Note A matures in 2 years, Note B matures in 3 years. If you don't raise Series A before Note A matures, you need to handle Note A separately (extend, convert, repay). This creates a cascading management problem.

For founders: track maturity dates on all convertible notes. Plan to raise Series A before the earliest maturity date (with buffer for due diligence and negotiations). If you won't hit Series A by maturity, begin conversations with note investors 6 months before maturity about extension or conversion.

The Governance Question: Do Convertible Notes Give Investors Governance Rights?

Most standard convertible notes don't include governance rights (board seat, consent rights on major decisions). But some do, especially larger rounds or from institutional investors. Check your note terms.

This is important because a convertible note investor without governance rights is passive (they own equity in the future but have no control today). A note investor with governance rights has control (board seat, information rights, consent rights on hiring, financing, etc.). Governance rights can be more valuable than the economics of the note.

When negotiating: resist governance rights in convertible notes if possible. Governance should come in priced equity rounds where valuation is certain and the investor's stake is clear. Governance in a convertible note creates control asymmetry (investor has control but contingent ownership). That's usually unfavorable to founders.

Multiple Convertible Rounds and the Series A Stack

Many startups raise seed-stage convertible notes (pre-seed, seed, seed extension) before a Series A. Each round is a separate convertible note with its own terms (cap, discount, interest). When you get to Series A, all notes convert simultaneously at the Series A valuation. If each note has different caps and discounts, the conversion math becomes complex.

Example: Pre-seed note ($250K, $3M cap, 20% discount), Seed note ($750K, $5M cap, 15% discount), Series A ($2M at $8M post-money). The pre-seed converts using its $3M cap (more favorable than discount). The seed converts at $6.8M (15% off $8M, more favorable than $5M cap). Total note equity: ($250K / $3M) + ($750K / $6.8M) = 8.3% + 11% = 19.3%. Founders are diluted by 19.3% to account for notes.

This multi-note scenario is common and manageable, but it requires careful tracking and communication with all note holders about conversion terms.

Key Takeaways

• Convertible notes are equity instruments, not debt; they're designed to convert into stock in a future funding round, not be repaid
• SAFEs are modern convertible notes without interest or maturity dates; simpler and cleaner for most seed-stage companies
• Conversion is determined by either valuation cap (maximum valuation at which note converts) or discount (percentage discount to Series A price), whichever is more favorable to the investor
• Accrued interest increases the principal amount that converts, increasing investor ownership percentage without any cash payment
• Convertible notes defer dilution to a future funding round; you'll be diluted in Series A when notes convert, even though you appear undiluted pre-Series A
• Understand the future dilution impact when raising convertible notes; that future dilution is a real cost
• Resist governance rights in convertible notes; governance should come in priced equity rounds with clear ownership
• Track maturity dates on convertible notes; plan Series A before earliest maturity to avoid renegotiation requirements
• Multiple seed-stage convertible rounds stack: each has its own cap and discount, creating complex conversion math in Series A

FAQ

Do we have to repay convertible notes if the company fails?

No. Convertible notes are equity-like in their risk profile: if the company fails, the investor loses their investment (along with equity holders). Note investors don't have priority over equity holders in liquidation (in fact, they're usually treated as equity holders in conversion). The note is not secured debt.

Can we negotiate the valuation cap down?

Yes, valuation caps are negotiable. A higher cap is better for you (less investor benefit if you're worth a lot at Series A). A lower cap is better for the investor (greater benefit). Typical ranges are $3M-$7M caps for pre-seed notes, $5M-$15M for seed notes. Negotiate based on your confidence in future valuation.

Is 20% discount typical?

Yes, 15-25% discount is standard. 20% is middle-market. Early-stage pre-seed notes might have 25-30% discount (to compensate for higher risk). Later-stage seed notes might have 10-15% discount. Interest rates of 4-6% are typical.

What happens if our Series A valuation is very high or very low?

High valuation: note holders benefit from caps (they convert at the cap, not the high series valuation). You lose some dilution savings. Low valuation: note holders lose (convert at low valuation). You benefit (lower effective dilution from notes). This is why valuation cap negotiation matters.

Can convertible notes be repaid early?

Usually yes, but it's rare. If your company is generating significant cash, you could theoretically pay off note investors at face value plus interest. But this is inefficient (you're reducing cash for investors who don't expect repayment). Better to extend maturity or convert at a negotiated valuation if needed.